Dr. Hingorani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6620
Education & Training
- Montefiore Medical Center/Albert Einstein College of MedicineFellowship, Pediatric Hematology/Oncology, 2005 - 2008
- SUNY Downstate Health Sciences UniversityResidency, Pediatrics, 2002 - 2005
- Maulana Azad Medical CollegeClass of 2000
Certifications & Licensure
- AZ State Medical License 2008 - 2025
- TX State Medical License 2019 - 2022
- OK State Medical License 2020 - 2021
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Bosutinib in Pediatric Patients With Newly Diagnosed Chronic Phase or Resistant/Intolerant Ph + Chronic Myeloid Leukemia Start of enrollment: 2020 Apr 06
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 32 citationsBody mass index (BMI) at diagnosis is associated with surgical wound complications in patients with localized osteosarcoma: A report from the Children's Oncology GroupPooja Hingorani, Kristy Seidel, Mark Krailo, Leo Mascarenhas, Paul A. Meyers
Pediatric Blood & Cancer. 2011-12-01 - 13 citationsPhase II results from a phase I/II study to assess the safety and efficacy of weekly nab-paclitaxel in paediatric patients with recurrent or refractory solid tumours: ...Loredana Amoroso, Victoria Castel, Gianni Bisogno, Michela Casanova, Catalina Marquez-Vega
European Journal of Cancer. 2020-08-01 - 25 citationsPhase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapie...Lucas Moreno, Michela Casanova, Julia C. Chisholm, Pablo Berlanga, Pascal Chastagner
European Journal of Cancer. 2018-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: